AR108591A1 - Composición acuosa que contiene atropina - Google Patents

Composición acuosa que contiene atropina

Info

Publication number
AR108591A1
AR108591A1 ARP170101418A ARP170101418A AR108591A1 AR 108591 A1 AR108591 A1 AR 108591A1 AR P170101418 A ARP170101418 A AR P170101418A AR P170101418 A ARP170101418 A AR P170101418A AR 108591 A1 AR108591 A1 AR 108591A1
Authority
AR
Argentina
Prior art keywords
buffer
aqueous composition
composition according
atropina
composition containing
Prior art date
Application number
ARP170101418A
Other languages
English (en)
Spanish (es)
Inventor
Toyomi Fujisawa
Takashi Morimoto
Koji Sakanaka
Kyohei Takahashi
Hiroyuki Asada
Roger Beuerman
Donald Tan
Original Assignee
Singapore Health Serv Pte Ltd
Univ Nanyang Tech
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=60411416&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR108591(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Singapore Health Serv Pte Ltd, Univ Nanyang Tech, Santen Pharmaceutical Co Ltd filed Critical Singapore Health Serv Pte Ltd
Publication of AR108591A1 publication Critical patent/AR108591A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/08—Mydriatics or cycloplegics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Photolithography (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
ARP170101418A 2016-05-25 2017-05-24 Composición acuosa que contiene atropina AR108591A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SG10201604200P 2016-05-25

Publications (1)

Publication Number Publication Date
AR108591A1 true AR108591A1 (es) 2018-09-05

Family

ID=60411416

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP170101418A AR108591A1 (es) 2016-05-25 2017-05-24 Composición acuosa que contiene atropina

Country Status (15)

Country Link
US (2) US20210267885A1 (enExample)
EP (2) EP3463360B1 (enExample)
JP (6) JP6590860B2 (enExample)
KR (4) KR102580933B1 (enExample)
CN (3) CN117205210A (enExample)
AR (1) AR108591A1 (enExample)
CA (1) CA3023149C (enExample)
EA (1) EA201892703A1 (enExample)
ES (1) ES2929368T3 (enExample)
MY (1) MY189774A (enExample)
PH (1) PH12018502421A1 (enExample)
SG (1) SG11201809822SA (enExample)
TW (3) TWI791438B (enExample)
UA (1) UA126195C2 (enExample)
WO (1) WO2017204262A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016172712A2 (en) * 2015-04-23 2016-10-27 Sydnexis, Inc. Ophthalmic composition
US9421199B2 (en) 2014-06-24 2016-08-23 Sydnexis, Inc. Ophthalmic composition
EP3302426A4 (en) 2015-05-29 2018-12-05 Sydnexis, Inc. D2o stabilized pharmaceutical formulations
KR20200007769A (ko) 2017-02-21 2020-01-22 싱가포르 헬스 서비시즈 피티이 엘티디 아트로핀을 포함하는 근시의 발병을 방지 또는 지연하기 위한 조성물 및 방법
US10251875B2 (en) 2017-05-11 2019-04-09 Nevakar Inc. Atropine pharmaceutical compositions
CN110934816B (zh) * 2018-09-25 2022-04-08 沈阳兴齐眼科医院有限公司 一种提高低浓度阿托品眼用制剂稳定性的方法
CN110934869B (zh) * 2018-09-25 2023-07-04 沈阳兴齐眼药股份有限公司 一种阿托品药物组合物和药盒产品
EP3701938B8 (en) 2019-03-01 2024-02-21 Medivis S.R.L. Ophthalmic formulations based on atropine
TWI907473B (zh) * 2020-08-04 2025-12-11 日商參天製藥股份有限公司 治療近視、預防近視及/或抑制近視進展之藥劑
AU2021362374A1 (en) * 2020-10-14 2023-05-25 Santen Pharmaceutical Co., Ltd. Stable pharmaceutical composition
EP4237421A4 (en) 2020-11-02 2024-11-06 Trethera Corporation CRYSTALLINE FORMS OF A DEOXYCYTIDINE KINASE INHIBITOR AND THEIR USES
WO2022130337A1 (en) * 2020-12-17 2022-06-23 Sun Pharmaceutical Industries Limited An aqueous sterile solution of atropine for ophthalmic use
EP4088714A1 (en) 2021-05-10 2022-11-16 Warszawskie Zaklady Farmaceutyczne Polfa S.A. Ophthalmic pharmaceutical composition comprising atropine
EP4088713A1 (en) 2021-05-10 2022-11-16 Warszawskie Zaklady Farmaceutyczne Polfa S.A. Ophthalmic pharmaceutical composition comprising atropine
US20230120997A1 (en) * 2021-10-18 2023-04-20 Ocular Science, Inc. Compositions and methods for myopia control and orthokeratology lenses treatment
CN114129511A (zh) * 2021-12-07 2022-03-04 河南润弘制药股份有限公司 一种具有改进稳定性的硫酸阿托品注射液
CN119110721A (zh) * 2022-09-11 2024-12-10 爱尔康公司 包含苄基阿托品的水性药物组合物及其用途
JP7665073B1 (ja) 2024-04-05 2025-04-18 ロート製薬株式会社 容器に収容してなる眼科用組成物
JP7723851B1 (ja) * 2024-11-22 2025-08-14 参天製薬株式会社 アトロピン含有水性医薬組成物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2617508B2 (ja) * 1988-02-05 1997-06-04 エーザイ株式会社 安定なジフェンヒドラミン含有水溶液
US5612027A (en) * 1995-04-18 1997-03-18 Galin; Miles A. Controlled release of miotic and mydriatic drugs in the anterior chamber
JP3166002B2 (ja) * 1997-01-27 2001-05-14 日本車輌製造株式会社 自動車の洗浄装置
US20030096831A1 (en) 2000-01-18 2003-05-22 Stone Richard A. Ocular growth and nicotinic antagonists
BR0210013A (pt) * 2001-05-25 2004-08-10 Valley Forge Pharmaceuticals Gel oftálmico de pirenzepina
US20070254914A1 (en) * 2006-05-01 2007-11-01 Non-Profit Organization Chang Gung Memorial Hospital Low-concentration atropine solution for preventing myopia progression and preparing method thereof
JP2007308398A (ja) * 2006-05-17 2007-11-29 Chang Gung Memorial Hospital 目薬、及びその製造方法
CA2688811A1 (en) * 2007-05-21 2008-11-27 Neuroptix Corporation Ophthalmic formulations of amyloid-beta contrast agents and methods of use thereof
CN101327216A (zh) * 2007-06-22 2008-12-24 肖正连 一种硫酸阿托品眼用即型凝胶
WO2012161655A1 (en) * 2011-05-23 2012-11-29 Singapore Health Services Pte Ltd Composition and/or method for reducing and/or preventing myopia progression comprising atropine
US9421199B2 (en) * 2014-06-24 2016-08-23 Sydnexis, Inc. Ophthalmic composition
US20160009705A1 (en) 2014-06-24 2016-01-14 Sydnexis, Inc. Ophthalmic composition
CN104983739B (zh) * 2015-06-25 2018-01-16 成都乾坤动物药业股份有限公司 一种多功能药物组合及其制备方法和应用
JP2017102939A (ja) * 2016-12-26 2017-06-08 株式会社プロフィールド オーサリング装置、オーサリング方法、およびプログラム
US10251875B2 (en) * 2017-05-11 2019-04-09 Nevakar Inc. Atropine pharmaceutical compositions

Also Published As

Publication number Publication date
US20240307305A1 (en) 2024-09-19
JP2023058574A (ja) 2023-04-25
TWI849355B (zh) 2024-07-21
UA126195C2 (uk) 2022-08-31
KR102580933B1 (ko) 2023-09-19
CN109310687A (zh) 2019-02-05
JP7224390B2 (ja) 2023-02-17
ES2929368T3 (es) 2022-11-28
TW202325296A (zh) 2023-07-01
KR20230141882A (ko) 2023-10-10
EP3463360A4 (en) 2020-01-29
CN117205210A (zh) 2023-12-12
KR20250067951A (ko) 2025-05-15
JP2025176149A (ja) 2025-12-03
JP6886502B2 (ja) 2021-06-16
MY189774A (en) 2022-03-04
KR20190013877A (ko) 2019-02-11
CN117205209A (zh) 2023-12-12
CA3023149C (en) 2024-07-02
CN109310687B (zh) 2023-10-20
WO2017204262A1 (en) 2017-11-30
KR20220154842A (ko) 2022-11-22
TWI791438B (zh) 2023-02-11
JP2025084921A (ja) 2025-06-03
EP4112055A1 (en) 2023-01-04
CA3023149A1 (en) 2017-11-30
KR102804061B1 (ko) 2025-05-07
EP3463360A1 (en) 2019-04-10
JP2018021007A (ja) 2018-02-08
JP6590860B2 (ja) 2019-10-16
EA201892703A1 (ru) 2019-04-30
EP3463360B1 (en) 2022-08-31
TW202206070A (zh) 2022-02-16
TW201808289A (zh) 2018-03-16
US20210267885A1 (en) 2021-09-02
JP2020007356A (ja) 2020-01-16
JP2021120404A (ja) 2021-08-19
PH12018502421A1 (en) 2019-09-30
TWI874894B (zh) 2025-03-01
SG11201809822SA (en) 2018-12-28

Similar Documents

Publication Publication Date Title
EA201892703A1 (ru) Водная композиция, содержащая атропин
BR112022004514A2 (pt) Produto oral com uma amina básica e um agente de pareamento iônico
CO2019005729A2 (es) Preparación de complejos sólidos de ciclodextrina para suministro de ingredientes farmacéuticos activos oftálmicos
BR112017003302A2 (pt) sal de adição de ácido do composto inibidor de trk
AR074541A1 (es) Composiciones desinfectantes de plata naturales
JP2018021007A5 (enExample)
AR103069A1 (es) Agente ampifílico de suspensión y estabilización para composiciones anticaspa para cuidado del cabello
AR105199A1 (es) Soluciones oftálmicas acuosas
MX2020011849A (es) Detergente enzimático de multiples usos y métodos de estabilizar una solución de uso.
BR112018000701A2 (pt) composição de limpeza não corrosiva, altamente alcalina
MX2017008189A (es) Composicion farmceutica que comprende plasminogeno y usos de este.
MX2018004033A (es) Composicion acuosa que contiene dantroleno.
HRP20220793T1 (hr) Oftalmološki vodeni sastav
ZA202210899B (en) Solutons for increasing the stability and shelf life of an organ and tissue preservation solution
MX2013007502A (es) Solucion oftalmica que comprende diquafosol, metodo para producir la misma, y metodo para inhibir la formacion de precipitado insoluble.
MY209059A (en) Aqueous ophthalmic composition comprising diquafosol or salt thereof and polyvinylpyrrolidone
MX2015017854A (es) Composicion que comprende glutamico-n, n-diacetato (glda), agua y enzima.
RU2017102325A (ru) Препарат рокурония с улучшенной стабильностью
AR132013A2 (es) Composición de propionato de calcio y agua
CL2017001039A1 (es) Composiciones anti-transpirantes anhidras
AR087371A1 (es) Formulaciones de (trimetoxifenilamino)pirimidinilo, metodos
UY35521A (es) Composición ecológica para curtido
MX345216B (es) Solucion oftalmica que contiene acido hialuronico o sal del mismo y propilenglicol.
AR089831A1 (es) Una composicion y un metodo para tratar sustratos
MX376456B (es) Composición acuosa con contenido de metal oligodinámico.

Legal Events

Date Code Title Description
FC Refusal